Iris van Wissen

March 1, 2022

Iris van Wissen

Researcher at Hybridize Therapeutics with the ambition to improve the lives of kidney patients. She has a Bio-Pharmaceutical Sciences background and worked before at the Target Discovery and Validation department of Galapagos.